PMVP - Balance Sheet - PMV Pharmaceuticals, Inc.

Current Liabilities	14.4 M
Accounts Payable	6.58 M
Short-Term Debt	352 K
Other Current Liabilities	7.44 M
Non-Current Liabilities	838 K
Long-Term Debt	838 K
Other Non-Current Liabilities	0

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
ASSETS
Cash & Cash Equivalents	40.9	37.7	108.3	172.5	361.4	73.3	30.3
Short Term Investments	128.6	165.4	132.8	124.7	0	28.2	31.6
Receivables	0	0	0	0	0	0	0
Inventory	0	0	0	0	0	0	0
Other Current Assets	6.2	4.4	6.0	4.1	6.7	0.6	0.3
Total Current Assets	175.7	207.4	247.0	301.3	364.8	102.1	62.2
PP&E	1.6	19.0	20.5	13.2	0.6	0.7	1.0
Intangible Assets	0	0	0	0	0	0	0
Goodwill	0	0	0	0	0	0	0
Long Term Investments	13.8	25.5	2.5	16.9	0	0	0
Other Long Term Assets	0.2	0.2	0.3	0.2	0.2	0.2	0.2
Other Assets	0	0	0	0	0	0	0
Total Assets	191.3	252.2	270.3	331.6	365.5	103.0	63.5
LIABILITIES
Accounts Payable	6.6	3.2	3.0	3.2	1.6	2.8	1.0
Short Term Debt	0.4	0.9	1.1	0.8	0	0	0
Other Current Liabilities	7.4	9.9	6.8	8.2	4.8	1.7	1.3
Total Current Liabilities	14.4	14.0	10.8	12.2	6.4	4.5	2.3
Long Term Debt	0.8	12.4	13.4	10.8	0	0	0
Deferred Tax Income	0	0	0	0	0	0	0
Other Liabilities	0	0	0	0	0	169.0	107.3
Total Liabilities	15.2	26.5	24.3	23.0	6.4	173.5	109.6
EQUITY
Common Stock	0	0	0	0	0	0	0
Retained Earnings	(368.7)	(310.0)	(241.0)	(167.7)	(109.9)	(75.4)	(50.1)
Other Accumulative Comprehensive Income/Loss	0.1	0.2	(0.4)	78 K	0	3 K	13 K
Total Equity	176.1	225.7	246.0	308.6	359.1	(70.5)	(46.1)
Total Liabilities and Equity	191.3	252.2	270.3	331.6	365.5	103.0	63.5
SHARES OUTSTANDING
Common Shares Outstanding	51.6	48.0	45.6	45.1	44.8	43.0	31.2

Free